Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2093 (LINC02093)
- Target
- LINC02093
- Molecular classification
- Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA)
01
Overview
Long intergenic non-protein coding RNA 2093 (LINC02093) is a human lincRNA gene, annotated in Genecards, NCBI, and Ensembl. It represents a class of autonomously transcribed non-coding RNAs longer than 200 nucleotides, situated in intergenic regions, and does not encode any known protein product. LINC02093's specific physiological functions and disease links have not been characterized, but similar lincRNAs participate in gene regulation, chromatin remodeling, and RNA processing. As of the current annotation, LINC02093 is not a therapeutic target, and no drugs or disease associations have been reported.
- Other names
- LINC02093long intergenic non-protein coding RNA 2093
02
Mechanism of action
Not applicable; no drugs are known to target LINC02093
03
Biological functions
Regulation of gene expression, including neighboring gene fine-tuningRemodelling of chromatin and genome architectureRNA stabilizationTranscription regulation (including enhancer-associated activity)Some lincRNAs may encode micropeptides or possess sequence-independent regulatory functions, but no evidence for this specific locus
04
Disease associations
No direct disease associations or therapeutic disease roles for LINC02093 are reported in major databases as of September 2025Some lincRNAs participate in cancer and other diseases, but this is not documented for LINC02093 specifically
05
Safety considerations
None reported or expected, since LINC02093 is not a direct therapeutic target
06
Interacting drugs
None reported for LINC02093
07
Biomarkers
No biomarker usage for patient selection or efficacy monitoring is documented for LINC02093
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2093 (LINC02093).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2093 (LINC02093).